<DOC>
	<DOCNO>NCT01893489</DOCNO>
	<brief_summary>Until , specific atherosclerosis-targeting agent label positron emitter yet available . Investigators develop neomannosyl human serum albumin ( MSA ) terminal mannose residue MSA bind mannose receptor macrophage atherosclerosis , investigator investigate whether 68Ga-MSA novel agent non-invasive molecular imaging carotid atherosclerotic lesion PET .</brief_summary>
	<brief_title>Visualization Carotid Atherosclerosis 68Ga-MSA</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>•coronary artery disease patient carotid plaque control without carotid plaque •pregnancy , allergy albumin , acute chronic inflammatory disease , hematologic disease , liver disease , renal disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>positron emission tomography</keyword>
	<keyword>macrophage</keyword>
	<keyword>neomannosyl human serum albumin</keyword>
</DOC>